EXHIBIT 99.1 Valneva to Present on its Chikungunya Vaccine Candidate and Host a Roundtable at the 23rd World Vaccine Congress in Washington D.C. Saint Herblain (France), March 30, 2023 –Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today it will present on its single-shot chikungunya vaccine candidate, VLA1553, and host a roundtable on Zika vaccines next week at the 23 World Vaccine Congress in Washington, D.C. On April 4, 2023, at 11.40am EDT, Valneva's Chief Medica ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 13(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ...

Valneva SE (NASDAQ:VALN) Q4 2022 Earnings Conference Call March 23, 2023 10:00 AM ET Company Participants Joshua Drumm - Vice President of Investor Relations Thomas Lingelbach - Chief Executive Officer Peter Buhler - Chief Financial Officer Conference Call Participants Maury Raycroft - Jefferies Evan Wang - Guggenheim Securities Max Herrmann - Stifel Nicolaus Rajan Sharma - Goldman Sachs Samir Devani - Rx Securities Operator 0Good day, and thank you for standing by. Welcome to the Valneva Full-Year 2022 Fin ...

Valneva SE (NASDAQ:VALN) Q3 2022 Earnings Conference Call November 10, 2022 9:00 AM ET Company Participants Thomas Lingelbach – President and Chief Executive Officer Peter Buhler – Chief Financial Officer Conference Call Participants Maury Raycroft – Jefferies Samir Devani – Rx Securities Evan Wang – Guggenheim Partners Max Herrmann – Stifel Arsene Guekam – Kepler Cheuvreux Olga Smolentseva – Bryan Garnier Nick Hallatt – Goldman Sachs Operator Good day, and thank you for standing by. Welcome to the Valneva ...

20,250,000 Ordinary Shares, 375,000 American Depositary Shares, each representing two Ordinary Shares, nominal value €0.15 per share Underwriting Agreement September 29, 2022 (New York City time) September 30, 2022 (Central European time) Goldman Sachs Bank Europe SE Jefferies LLC Jefferies GmbH As representatives (the "Representatives") of the several Underwriters named in Schedule I hereto c/o Goldman Sachs Bank Europe SE Marienturm, Taunusanlage 9-10 60329 Frankfurt am Main Germany c/o Jefferies LLC 520 ...

Valneva HY Results 2022 VALNEVA SE H1 2022 TABLE OF CONTENTS All forward-looking statements in this interim financial report are subject to change or adjustments as a result of uncertainties inherent in all research and development activities, as well as the economic, financial, competitive and regulatory environment. In addition, the Group's business activities and its ability to meet its targets and forecasts may be affected if some of the risk factors described in chapter 1.5 – "Risk factors" of this int ...

Valneva SE (NASDAQ:VALN) Q1 2022 Earnings Conference Call May 5, 2022 10:00 AM ET Company Participants Thomas Lingelbach - Chief Executive Officer Peter Buhler - Chief Financial Officer Franck Grimaud - Chief Business Officer Conference Call Participants Samir Devani - Rx Securities Maury Raycroft - Jefferies Max Herrmann - Stifel Financial Corp. Evan Wang - Guggenheim Securities Jean-Jacques Le Fur - Bryan Garnier Franck Grimaud - Chief Business Officer Sebastiaan van der Schoot - Kempen & Company Thomas L ...

Valneva SE (NASDAQ:VALN) Q4 2021 Earnings Conference Call March 24, 2022 10:00 AM ET Company Participants Thomas Lingelbach - Chairman, President and CEO Peter Buhler - CFO Conference Call Participants Maury Raycroft - Jeffries Seamus Fernandez - Guggenheim Securities Samir Devani - Rx Securities Limited Max Herrmann - Stifel, Nicolaus & Company, Inc. Operator Good day, and thank you for standing by. Welcome to the Valneva presents it's audited Full Year 2021 Financial Results Conference Call. At this time, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 13(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19 ...